From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
May 26, 2026
May 26, 2026
LA JOLLA, California, May 26 -- The Salk Institute for Biological Studies issued the following news release:
* * *
From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
Highlights
* Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin D-based therapy "reprogram" a pancreatic tumor's protective . . .
* * *
From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
Highlights
* Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin D-based therapy "reprogram" a pancreatic tumor's protective . . .